ADVANCED MALIGNANT TUMORS
Clinical trials for ADVANCED MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug SSGJ-709 enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug, SSGJ-709, in 15 adults with advanced solid tumors that have spread. The main goals are to check the drug's safety and how the body processes it. Researchers will also look for signs that the drug shrinks tumors.
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 26, 2026 10:17 UTC
-
New cancer drug SPGL008 enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug, SPGL008, in 96 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. Participants will receive the drug either through…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 26, 2026 10:17 UTC
-
New hope for advanced cancer patients: JMT108 enters human trials
Disease control Recruiting nowThis study tests a new drug called JMT108 in people with advanced cancers that have not responded to other treatments. The main goals are to check if the drug is safe and to find the best dose. About 436 adults will take part in this early-phase trial across multiple centers.
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New targeted drug shows promise in early cancer trial
Disease control Recruiting nowThis early-phase trial tests a new drug called TQB6411 in people with advanced cancers that have not responded to other treatments. The drug works like a guided missile, attaching to specific markers on cancer cells to deliver a toxin that kills them. The study aims to find the s…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC